样本有效性测试市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

样本有效性测试市场按产品和服务、类型(实验室测试、快速/POC 测试)、最终用户和地理位置细分

样本有效性测试市场快照

Specimen Validity Testing Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,所研究的样本有效性测试市场预计将以 6.3% 的复合年增长率增长。促成市场增长的重要因素是药物滥用人口数量的增加,药物筛选实验室数量的增加。越来越多的非法药物使用也促进了市场的增长。非法使用药物的特点是使用海洛因、可卡因、大麻、致幻剂、吸入剂或非医疗使用处方心理治疗药物(兴奋剂、镇静剂和止痛药)。根据 2012 年物质滥用和心理健康服务管理局 (SAMHSA) 公布的数据,在过去一个月中,近 2300 万 12 岁或以上的美国人从事非法药物的使用。这占人口的8.7%,使其成为美国严重的公共卫生问题 尿液药物筛查是一种临床方法,可以提高医院的安全性、跟踪患者对治疗的依从性、诊断药物滥用(非法和合法)以及处方药的转移. 所有这些上述因素都将在预测期内促进样本有效性测试的市场增长。

报告范围

尿液可能是检测滥用药物最广泛使用的样本。这主要是因为尿液很容易大量获得,并且含有大量的代谢物和外用药物。因此,对尿液样本进行样本有效性测试以进行筛查以检测药物滥用情况。

By Product & Service
Products
Assay Kits
Reagents and Calibators
Disposables
Service
By Type
Laboratory Testing
Rapid/POC Testing
By End-User
Drug Screening Laboratories
Pain Management Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

检测试剂盒部分预计将在样本有效性检测市场中占有最大的市场份额

  • 由于过去几年技术的不断进步等属性为该行业的增长开辟了许多机会,分析试剂盒部门保留了主导份额。药物滥用的增加正在帮助市场呈指数增长。
  • 不同国家/地区的政府越来越重视管理和提高对这些测试和测试的认识,导致这些测试在全球范围内迅速接受。 
Specimen Validity Testing Market

北美在市场上占主导地位,预计在预测期内也会如此

预计北美将在整个预测期内保持其在整个样本有效性测试市场的主导地位。这是由于该地区吸毒人数不断增加等因素造成的。政府制定了严格的指导方针来解决药物筛选产品的掺假问题,这是北美 SVT 行业的主要贡献者。另一个促进北美 SVT 行业发展的因素是越来越多的行业的出现,以及越来越多的就业前和工作场所随机药物测试正在进一步推动样本有效性测试市场的增长,并负责以确保区域主导地位。

Specimen Validity Testing Market

竞争格局

样本有效性测试市场竞争激烈,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。一些知名企业正在积极与其他公司进行合作、收购和推出新产品,以巩固其在全球的市场地位。目前主导市场的一些公司是 Alere Inc.、Thermo Fisher Scientific、LabCorp、American Bio Medica Corporation 和 Premier Biotech, Inc.。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Drug Screening Market

      2. 4.2.2 Increasing usage of illegal drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Limited awareness for SVT and emergence of other tests

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product & Service

      1. 5.1.1 Products

        1. 5.1.1.1 Assay Kits

        2. 5.1.1.2 Reagents and Calibators

        3. 5.1.1.3 Disposables

      2. 5.1.2 Service

    2. 5.2 By Type

      1. 5.2.1 Laboratory Testing

      2. 5.2.2 Rapid/POC Testing

    3. 5.3 By End-User

      1. 5.3.1 Drug Screening Laboratories

      2. 5.3.2 Pain Management Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alere Inc.

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 LabCorp

      4. 6.1.4 American Bio Medica Corporation

      5. 6.1.5 Premier Biotech, Inc.

      6. 6.1.6 Sciteck, Inc.

      7. 6.1.7 Alfa Scientific Designs

      8. 6.1.8 ACM Global Laboratories

      9. 6.1.9 Quest Diagnostics

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Specimen Validity Testing Market market is studied from 2018 - 2026.

The Specimen Validity Testing Market is growing at a CAGR of 6.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Alere Inc., Thermo Fisher Scientific, LabCorp, American Bio Medica Corporation, Premier Biotech, Inc. are the major companies operating in Specimen Validity Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!